Abstract
Purpose
This study compared the results of high-resolution computed tomography (HRCT) and cytohistology after transbronchial biopsy in the evaluation of drug-related interstitial lung disease (DR-ILD).
Materials and methods
Patients with a clinical and imaging diagnosis of DR-ILD were prospectively included in a study protocol lasting 5 years. All patients were evaluated by bronchoscopy with transbronchial biopsy or bronchoalveolar lavage (BAL) following an HRCT examination that raised a suspicion of DR-ILD. Two radiologists (one senior and one junior), unaware of the diagnosis, reported the single HRCT findings, their distribution and predominant pattern. In the event of disagreement, the diagnosis was subsequently reached by consensus. Cytohistological examination was considered the gold standard in the diagnosis of DR-ILD. Patients who were unable to undergo the endoscopic procedure were excluded from the study.
Results
The study included 42 patients (25 men, 17 women; age range 20–84 years). Transbronchial biopsy was performed in all but four patients (one case of alveolar haemorrhage and three cases of lipoid pneumonia) in whom the diagnosis was established with BAL. Assessment of the HRCT images revealed the following patterns: noncardiogenic pulmonary oedema (n=13); organising pneumonia (OP) (n=9); hypersensitivity pneumonitis (HP) (n=2); alveolar haemorrhage (AH) (n=2); nonspecific interstitial pneumonia (NSIP) (n=5); lipoid pneumonia (LP) (n=1); sarcoid-like pattern (n=1). Cytohistological diagnosis revealed diffuse alveolar damage (DAD) in 11 patients, OP in seven, HP in three, AH in three, chronic interstitial pneumonia (CIP) in eight, LP in three and pseudosarcoidosis in one. Subdivision of the drugs into antineoplastic and nonantineoplastic agents showed that the most common patterns were CIP (n=6), DAD (n=2) and OP (n=2) in the antineoplastic group and DAD (n=9) and OP (n=5) in the nonantineoplastic group. Sensitivity and specificity of the radiological analysis was excellent, especially for patterns such as OP and DAD (sensitivity 0.86 and specificity 0.88 for OP; sensitivity 1 and specificity 0.93 for DAD).
Conclusions
HRCT demonstrated excellent sensitivity and specificity. In cases in which its specificity was low, HRCT was nonetheless useful for biopsy planning and clinical-radiological monitoring after discontinuation of the drug treatment.
Riassunto
Obiettivo
Lo scopo del nostro lavoro è stato confrontare i reperti della tomografia computerizzata (TC) ad alta risoluzione (HRCT) con il dato cito-istologico fornito dalla biopsia transbronchiale, nella valutazione della tossicità polmonare farmaco indotta (DR-ILD).
Materiali e metodi
I pazienti con diagnosi clinicoradiologica di polmonite da farmaci sono stati prospettivamente inclusi in un protocollo di studio durato 5 anni. Tutti i pazienti erano sottoposti a broncoscopia, con biopsia transbronchiale o broncolavaggio (BAL) in seguito ad una HRCT che poneva il sospetto di DR-ILD. Due radiologi (un senior ed un junior) hanno riportato in cieco i dati riguardanti i singoli reperti, la distribuzione e il pattern predominante alla HRCT. In un secondo step, nei casi di rilevata discrepanza, la diagnosi è stata raggiunta per consenso. È stato considerato quale goal standard nel processo diagnostico di DR-ILD la diagnosi citoistologica. I pazienti che non potevano essere sottoposti a procedura endoscopica venivano esclusi dallo studio.
Risultati
Quarantadue pazienti sono stati inclusi nello studio (25 maschi; 17 femmine; range di età 20–84 anni). La biopsia transbronchiale è stata effettuata in tutti i casi, fatta eccezione per un caso di emorragia alveolare e tre casi di polmonite lipoidea, in cui la diagnosi è stata raggiunta con il BAL. Le interpretazioni TC includevano i seguenti pattern: edema polmonare non cardiogeno (n=13); organizing pneumonia (OP) (n=9); hypersensitivity pneumonitis (HP) (n=2); alveolar haemorrage (AH) (n=2); non specific interstitial pneumonia (NSIP) (n=5); lipoid pneumonia (LP) (n=1); sarcoid-like pattern (n=1). La diagnosi anatomopatologica ha mostrato: danno alveolare diffuso (DAD) in 11 pazienti, OP in 7, HP in 3, AH in 3, polmonite interstiziale cronica (CIP) in 8, LP in 3; pseudosarcoidosi in 1. Dividendo i farmaci in antineoplastici e nonantineoplastici, i pattern più frequenti sono stati CIP (n=6); DAD (n=2); OP (n=2) per il gruppo degli antineoplastici. I pattern predominanti dei nonantineoplastici sono stati: DAD (n=9) e OP (n=5). Eccellente è stata la sensibilità e la specificità dell’analisi radiologica, soprattutto per pattern quali OP e DAD (OP: sensibilità pari a 0,86; specificità pari a 0,88; DAD: sensibilità 1; specificità 0,93).
Conclusioni
La TC ad alta risoluzione ha mostrato un’eccellente sensibilità e specificità. Nei casi in cui la HRCT ha mostrato bassa specificità, è stata utile nel planning di una corretta biopsia e nel monitoraggio clnico-radiologico dopo la sospensione del farmaco.
Similar content being viewed by others
References/Bibliografia
Lindell RM, Hartman TE (2005) Chest imaging in iatrogenic respiratory disease. Radiol Clin N Am 43:601–610
Akira M, Ishikawa H, Yamamoto S (2002) Drug-related pneumonitis: thinsection CT findings in 60 patients. Radiology 224:852–860
Rossi SE, Erasmus JJ, McAdams P et al (2000) Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20:1245–1259
Muller NL, White DA, Jiang H, Gemma A (2004) Diagnosis and management of drug-associated interstitial lung disease. Br J Canc 91:S24–S30
Kuhlman JE (1991) The role of the chest computed tomography in the diagnosis of the drug-related reaction. J Thorac Imaging 6:52–61
Cleverley JR, Screaton NJ, Hiorns MP et al (2002) Drug-related lung disease: high resolution CT and histological findings. Clin Radiol 57:292–299
Akoun GM, Cadranel JL, Milleron BJ et al (1991) Bronchoalveolar lavage cell data in 19 patients with drugassociated pneumonitis. Chest 99:98–104
Cereser L, Zuiani C, Graziani G et al (2009) Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia. Radiol Med 115:205–214
Poletti V, Chilosi M, Olivieri D (2004) Diagnostic invasive procedures in diffuse infiltrativi lung diseases. Respiration 71:107–119
Webb WR (2006) Thin-Section CT of the secondary pulmonary lobule: anatomy and the image-the 2004 Fleischner lecture. Radiology 239:322–338
Kuhlman JE, Teigen C, Ren H et al (1990) Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 177:121–125
Rosenow EC, Myers JL, Swensen SJ, Pisani RJ (1992) Drug-related pulmonary disease: an update. Chest 102:239–250
Padley SPG, Adler B, Hansell DM, Muller NL (1992) High-resolution computed tomography of drug induced lung disease. Clin Radiol 46:232–236
Camus PH, Foucher P, Bonniaud PH, Ask K (2001) Drug-related infiltrative lung disease. Eur Respir J 32:93s–100s
Foucher P, Camus (2009) GEPPI. http://www.pneumotox.com. Accessed August 2010
Myers JL, Kennedy JI, Plumb VJ (1987) Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 18:349–354
American Thoracic Society, European Resiratory Society (2002) ATS/ERS Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. June 2001. Am J Respir Crit Care Med 165:277–304
Nishiyama O, Kondoh Y, Taniguchi H et al (2000) Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J Comput Assist Tomogr 24:41–46
Kuhlman JE, Teigen C, Ren H et al (1990) Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 177:121–125
Holoye PY, Jenkins DE, Greenberg SD (1976) Pulmonary toxicity in long term administration of BCNU. Cancer Treat Rep 60:1691–1694
Cooper JA, White DA, Matthay RA (1986) Drug-related pulmonary disease. Cytotoxic drugs. Am Rev Resp Dis 133:321–340
Kennedy J, Myers J, Plumb V, Fulmer J (1987) Amiodarone pulmonary toxicity: clinical, radiologic and pathologic correlations. Arch Intern Med 147:50–55
Meyers JL (1987) Pathology of drugrelated lung disease. In: Katzenstein AA (ed) Katzenstein and Askin’s surgical pathology of non-neoplastic lung disease. Saunders, Philadelphia, pp 4:81–111
Pietropaoli A, Modrak J, Utell M (1999) Interferon-therapy associated with the development of sarcoidosis. Chest 116:569–571
Vander E, Gerdes H (2000) Sarcoidosis and IFN-· treatment. Chest 117:294
Carloni A, Piciucchi S, Giannakakis K et al (2008) Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis. J Thorac Imaging 23:57–59
Naccache JM, Antoine M, Wislez M et al (1999) Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 159:2009–2013
Gondouin A, Manzoni PH, Ranfaing E (1996) Exogenous lipoid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J 9:1463–1469
Joshi RR, Cholankeril JV (1985) Computed tomography in lipoid pneumonia. J Comput Assist Tomogr 9:211–213
Bandla HR, Davis SH, Hopkins NE (1999) Lipoid pneumonia: a silent complication of mineral oil aspiration. Pediatrics 103:1–4
Travis WD, Hunninghake G, King TE et al (2008) Idiopathic nonspecific interstitial pneumonia. Report of an American Thoracic Society Project. Am J Resp Crit Care Med 177:1338–1347
White DA, Wong PW, Downey R (2000) The utility of open lung biopsy in hematologic patients with pulmonary infiltrates. Am Resp J Crit Care Med 161:723–729
Leslie KO, Gruden JF, Parish JM, Scholand MB (2007) Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131:407–423
Padley SPG, Adler B, Hansell DM, Müller NL (1992) High-resolution computed tomography of drug-induced lung disease. Clin Radiol 46:232–236
Berbescu EA, Katzenstein AA, Snow JL et al (2006) Transbronchial biopsy in usual interstitial pneumonia. Chest 129:1126–1131
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piciucchi, S., Romagnoli, M., Chilosi, M. et al. Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy. Radiol med 116, 246–263 (2011). https://doi.org/10.1007/s11547-010-0608-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-010-0608-y